Clinical Trial Update: A Study of CIN-107 in Patients With Uncontrolled Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial update for CIN-107 in patients with uncontrolled hypertension; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uncontrolled Hypertension

Drugs mentioned

• CIN-107

Snippet

Sponsor: CinCor Pharma, Inc. | Conditions: Uncontrolled Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2023-08-01